Press release Biocartis Group NV: SeptiCyte® RAPID Receives 510(k) clearance by US FDA

NEXT STORY
Eurobio Scientific Launches the First Pcr Test Allowing Simultaneous Sars-Cov-2 Virus Screening and Detection of the Delta and Omicron Variants in a Single Reaction
PREV STORY
Emergence of Zoonotic Infections Boosts Precision Medicine Market Growth At A Rate Of 16% As Per The Business Research Company’s Precision Medicine Global Market Report 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection

author_avatar
NASDAQ Market News

Aduro Biotech Appoints Dimitry S.A. Nuyten, M.D., Ph.D. as Chief Medical Officer

author_avatar
NASDAQ Market News

MediWound Hosting Analyst Day Webinar on EscharEx – Enzymatic Debridement Agent for Chronic Wounds

author_avatar
NASDAQ Market News